摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to a novel derivative of N-acylanthranilic acid, represented by the following general formula 1, or to its pharmaceutically acceptable salt, in which R, R, R, X, X, X, Xand A are determined in the invention formula.EFFECT: invention relates to an inhibitor of collagen production, a medication for treating diseases, associated with the excessive production of collagen, containing N-acylanthranilic acid derivativeFormula 1. |